Elizabeth Holmes testified Tuesday that she wishes she would have handled many aspects of her leadership at Theranos differently, including directing Boies Schiller Flexner to pursue legal action against purported whistleblowers.

The government’s first day of Holmes’ cross-examination worked to counter the Theranos founder’s testimony in direct that indicated second-in-command Ramesh “Sunny” Balwani concealed operational issues at the blood-testing company and that she didn’t have full agency over her decisions.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]